Back to Authors

Vargas, Bert B.

Mayo Clinic

The University of Texas Southwestern Medical Center

Citations 24

King-Devick Test identifies real-time concussion and asymptomatic concussion in youth athletes
Dhawan, Priya S., Leong, Danielle, Tapsell, Lisa, Starling, Amaal J. , Galetta, Steven , Balcer, Laura J. , Overall, Trenton L., Adler, Jennifer S. , Halker-Singh, Rashmi B., Vargas, Bert B., Galetta, Steven L, Dodick, David, Dodick, David W.

Neurology Clinical Practice | December 11, 2017 | Volume: 7 | Issue: 6 | Pages: 464-473

10.1212/cpj.0000000000000381 Get It

Feasibility and accuracy of teleconcussion for acute evaluation of suspected concussion
Vargas, Bert B., Shepard, M., Hentz, Joseph G. , Kutyreff, Cherisse, Hershey, L. George, Starling, Amaal J. , Shepard, Morgan

Neurology | March 25, 2017 | Volume: 88 | Issue: 16 | Pages: 1580-1583

10.1212/wnl.0000000000003841 Get It

The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students
Starling, Amaal J. , Wethe, Jennifer V. , Messner, Leonard V., Master, Christina L. , Halker-Singh, Rashmi B., Vargas, Bert B., Bogle, Jamie M. , Mandrekar, Jay , Talaber, Alexandra , Leong, Danielle, Dodick, David, Wethe, Jennifer, Dodick, David W. , Pang, Yi , Smith, Craig E. , Wethe, Jennifer V

Journal of Child Neurology | October 11, 2016 | Volume: 32 | Issue: 1 | Pages: 104-111

10.1177/0883073816668704 Get It

Efficient eye movements provide a physical foundation for proficient reading skills. We investigated the effect of in-school saccadic training on reading performance. In this cross-over design, study participants (n = 327, 165 males; mean age [SD]: 7 y 6 mo [1y 1 mo]) were randomized into treatment and control groups, who then underwent eighteen 20-minute training sessions over 5 weeks using King-Devick Reading Acceleration Program Software. Pre- and posttreatment reading assessments included fluency, comprehension, and rapid number naming performance. The treatment group had significantly greater improvement than the control group in fluency (6.2% vs 3.6%, P = .0277) and comprehension (7.5% vs 1.5%, P = .0002). The high-needs student group significantly improved in fluency ( P < .001) and comprehension ( P < .001). We hypothesize these improvements to be attributed to the repetitive practice of reading-related eye movements, shifting visuospatial attention, and visual processing. Consideration should be given to teaching the physical act of reading within the early education curriculum.
Chronic Daily Headache: Ten Steps for Primary Care Providers to Regain Control
Sheeler, Robert D. , Garza, Ivan , Vargas, Bert B., O’Neil, Angela E.

Headache: The Journal of Head and Face Pain | August 23, 2016 | Volume: 56 | Issue: 10 | Pages: 1675-1684

10.1111/head.12881 Get It

Background Chronic daily headache (CDH) affects 2% to 4% of the North American and European population. Various pathways lead to this condition, although chronification of migraine and the occurrence of central sensitization in tension headache are the 2 most common. Medication overuse headaches complicate a substantial portion of other primary headaches that have become chronic and often make their treatment more complex and less successful. Methods/Results A 10‐step process to help primary care providers evaluate and treat CDH patients begins with excluding secondary headache disorders, then moves on to classification of the primary underlying headache disorder. Next, the exacerbating factors, as well as relevant comorbid conditions, are identified. The patient's current acute therapy is examined, and attempts are made to identify and resolve medication overuse if present. Past preventive therapies are reviewed, allowing for thoughtful design of a headache action plan with preventive, acute, and lifestyle components. Patients are asked to keep a headache diary, used to initiate a cycle of continuous improvement in a patient's response to acute and preventive therapeutic approaches. Conclusions A systematic approach and partnership with patients often make it possible to convert CDH to episodic headache that is responsive to both acute and preventive therapies.
Variability of the modified Balance Error Scoring System at baseline using objective and subjective balance measures
Starling, Amaal J. , Leong, Danielle, Bogle, Jamie M. , Vargas, Bert B.

Concussion | August 18, 2015 | Volume: 1 | Issue: 1 | Pages: No page available

10.2217/cnc.15.5 Get It

Aim: To investigate preseason modified Balance Error Scoring System (mBESS) performance in a collegiate football cohort; to compare scores to an objective mobile balance measurement tool. Materials & methods: Eighty-two athletes completed simultaneous balance testing using mBESS and the King–Devick Balance Test, an objective balance measurement tool. Errors on mBESS and objective measurements in the double-leg, single-leg (SS) and tandem stances were compared. Results: Mean mBESS error score was 7.23 ± 4.65. The SS accounted for 74% of errors and 21% of athletes demonstrated the maximum error score. There was no significant correlation between mBESS score and objective balance score. Conclusion: The high variability and large number of errors in the SS raises concerns over the utility of the SS in identifying suspected concussion.
Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study
Dilli, Esma, Halker, Rashmi, Vargas, Bert B., Hentz, Joseph G. , Radam, Teresa, Rogers, Robert , Vargas, Bert, Hentz, Joseph, Dodick, David, Dodick, David W.

Cephalalgia | December 12, 2014 | Volume: 35 | Issue: 11 | Pages: 959-968

10.1177/0333102414561872 Get It

Background Occipital nerve (ON) injections with corticosteroids and/or local anesthetics have been employed for the acute and preventive treatment of migraine for decades. However, to date there is no randomized, placebo-controlled evidence to support the use of occipital nerve block (ONB) for the prevention of migraine. Objective The objective of this article is to determine the efficacy of ONB with local anesthetic and corticosteroid for the preventive treatment of migraine. Participants and methods Patients between 18 and 75 years old with ICHD-II-defined episodic (> 1 attack per week) or chronic migraine (modified ICHD-II as patients with > 10 days with consumption of acute medications were permitted into the study) were randomized to receive either 2.5 ml 0.5% bupivacaine plus 0.5 ml (20 mg) methylprednisolone over the ipsilateral (unilateral headache) or bilateral (bilateral headache) ON or 2.75 ml normal saline plus 0.25 ml 1% lidocaine without epinephrine (placebo). Patients completed a one-month headache diary prior to and after the double-blind injection. The primary outcome measure was defined as a 50% or greater reduction in the frequency of days with moderate or severe migraine headache in the four-week post-injection compared to the four-week pre-injection baseline period. Results Thirty-four patients received active and 35 patients received placebo treatment. Because of missing data, the full analysis of 33 patients in the active and 30 patients in the placebo group was analyzed for efficacy. In the active and placebo groups respectively, the mean frequency of at least moderate (mean 9.8 versus 9.5) and severe (3.6 versus 4.3) migraine days and acute medication days (7.9 versus 10.0) were not substantially different at baseline. The percentage of patients with at least a 50% reduction in the frequency of moderate or severe headache days was 30% for both groups (10/30 vs nine of 30, Δ 0.00, 95% CI –0.22 to 0.23). Conclusions Greater ONB does not reduce the frequency of moderate to severe migraine days in patients with episodic or chronic migraine compared to placebo. The study was registered with ClinicalTrial.gov (NCT00915473).
Imploding and Exploding Migraine Headaches: Comparison of Methods to Diagnose Pain Directionality
Files, Julia A. , Schwedt, Todd J. , Mayer, Anita P. , David, Paru S., Vargas, Bert B., Hunt, Megan J. Olson , Patel, Salma , Ko, Marcia G., Tozer, Beverly S., Chang, Yu‐Hui , Burstein, Rami , Dodick, David W. , Schwedt, Todd J

Headache: The Journal of Head and Face Pain | February 17, 2014 | Volume: 54 | Issue: 6 | Pages: 1010-1018

10.1111/head.12335 Get It

Background The study aims to compare methods of determining headache directionality (imploding, exploding, and/or ocular headaches) in women with migraine, investigate the concordance between physician assignment and patient self‐assignment of pain directionality, and evaluate whether patients assigned their headaches to the same direction when queried using different methods. Directionality of migraine headache pain (imploding, exploding, or ocular) may reflect differences in the underlying pathogenesis of individual migraine attacks among and within individuals. Emerging evidence suggests that directionality of pain in migraine sufferers may predict response to onabotulinumtoxin A . The best method of determining headache directionality in migraine sufferers has not been systematically explored. Methods We conducted a prospective cross‐sectional survey study of 198 female patients with migraine presenting to a W omen's H ealth C linic. Patients determined the directionality (imploding, exploding, and/or ocular) of their own migraine pain by choosing among 3 pictures graphically representing directionality and also by responding to a written question regarding directionality. Clinicians then classified directionality of migraine pain using structured interviews. Concordance between clinician assignment of directionality and patient self‐assignment was determined with K appa coefficients. Results Subjects were females between the ages of 18 and 77 years (mean 48 years). According to patient selection of representative pictures, 62 (31.6%) had imploding headaches with or without ocular pain, 36 (18.4%) had exploding headaches with or without ocular pain, 78 (39.8%) had ocular pain only, and 20 (10.2%) had imploding and exploding headaches with or without ocular pain. Two subjects did not respond. According to patient responses to a written question, 80 (41.0%) had imploding headaches with or without ocular pain, 53 (27.2%) had exploding headaches with or without ocular pain, 46 (23.6%) had ocular pain only, and 16 (8.2%) had imploding and exploding headaches with or without ocular pain. Three subjects did not respond. For physician assignment, 69 (34.9%) subjects had imploding headaches with or without ocular pain, 89 (45%) had exploding headaches with or without ocular pain, 14 (7.1%) had ocular pain only, and 26 (13.1%) had imploding and exploding headaches with or without ocular pain. The concordance ( K appa coefficient) between physician assignment of headache directionality with patient response to the written question was 0.33 (weak agreement), between physician assignment and patient assignment via selection of representative pictures was 0.35 (weak agreement), and between patient assignment via written question and via selection of representative pictures was 0.35 (weak agreement). Conclusions The assignment of headache directionality varied substantially depending upon the method of determination. The concordance between clinician assignment, patient‐self assignment via answering a written question, and patient self‐assignment via choosing a representative picture was weak. Improved methods of determining pain directionality are needed.
Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak
Starling, Amaal J. , Hernandez, F. Saez, Hoxworth, Joseph M. , Trentman, Terrence L. , Halker, Rashmi, Vargas, Bert B., Hastriter, Eric V. , Starling, Amaal, Dodick, David W. , Hoxworth, Joseph M

Neurology | October 11, 2013 | Volume: 81 | Issue: 20 | Pages: 1789-1792

10.1212/01.wnl.0000435555.13695.22 Get It

Calcitonin gene-related peptide receptor antagonists
Bravo, Thomas P., Vargas, Bert B., Halker, Rashmi

Novel Approaches in Migraine Treatment | August 23, 2013 | Volume: No volume available | Issue: No issue available | Pages: 22-35

10.2217/ebo.13.261 Get It

Pathophysiology of migraine & triptan mechanism of action
Halker, Rashmi, Vargas, Bert B.

Triptans for Migraine | March 26, 2013 | Volume: No volume available | Issue: No issue available | Pages: 6-15

10.2217/ebo.11.391 Get It